CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor
- 1 April 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 255 (1-3) , 17-24
- https://doi.org/10.1016/0014-2999(94)90077-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- No-Mimetic Furoxans: Arylsulphonylfuroxans and Related CompoundsPharmacological Research, 1993
- 1,1-Dinitroethyl substituted furoxans: a new class of vasodilators and inhibitors of platelet aggregationEuropean Journal of Medicinal Chemistry, 1993
- Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxansBiochemical Pharmacology, 1992
- Characterization of a new compound, S35b, as a guanylate cyclase activator in human plateletsBiochemical Pharmacology, 1992
- Endothelium‐derived nitric oxide: actions and propertiesThe FASEB Journal, 1989
- Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilatorBritish Journal of Pharmacology, 1988
- The Role of Endothelium in the Responses of Vascular Smooth Muscle to DrugsAnnual Review of Pharmacology and Toxicology, 1984
- Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsAnalytical Biochemistry, 1982
- The aggregation of blood plateletsThe Journal of Physiology, 1963
- The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobinThe Journal of Physiology, 1957